World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
41700
World Ranking
18235
National Ranking
9095

Overview

Jerzy Lasota is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with specific subfields that include Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine, and Surgery.

The scientist's main topics of study encompass several areas: sarcoma diagnosis and treatment, tumors and oncological cases, genetic factors in colorectal cancer, peptidase inhibition and analysis, gastrointestinal tumor research and treatment, vascular tumors and angiosarcomas, and PARP inhibition in cancer therapy.

Lasota has an active publication record with notable papers such as:

  • Colorectal Adenocarcinomas Harboring ALK Fusion Genes, 2020, The American Journal of Surgical Pathology
  • PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors, 2022, The American Journal of Surgical Pathology
  • Gastrointestinal stromal tumours, 2021, Nature Reviews Disease Primers
  • Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology, 2023, The American Journal of Surgical Pathology
  • Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature, 2022, Modern Pathology

The venues where Lasota has frequently published include:

  • The American Journal of Surgical Pathology
  • The Journal of Pathology Clinical Research
  • Applied Immunohistochemistry & Molecular Morphology
  • Nature Reviews Disease Primers
  • Modern Pathology

Among frequent co-authors collaborating extensively with Lasota are:

  • Markku Miettinen
  • Maciej Kaczorowski
  • Małgorzata Chłopek
  • Janusz Ryś
  • Artur Kowalik

Best Publications

  • Diagnosis of gastrointestinal stromal tumors: A consensus approach.

    Christopher D.M. Fletcher;Jules J. Berman;Christopher Corless;Fred Gorstein

  • Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

    Markku Miettinen;Jerzy Lasota

  • Gastrointestinal stromal tumors: Pathology and prognosis at different sites

    Markku Miettinen;Jerzy Lasota

  • Gastrointestinal Stromal Tumors: Review on Morphology, Molecular Pathology, Prognosis, and Differential Diagnosis

    Markku Miettinen;Jerzy Lasota

  • Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

    Markku Miettinen;Leslie H Sobin;Jerzy Lasota

  • Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases

    Markku Miettinen;Janusz Kopczynski;Hala R. Makhlouf;Maarit Sarlomo-Rikala

  • Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.

    Markku Miettinen;Wa'el El-Rifai;Wa'el El-Rifai;Leslie H L Sobin;Leslie H L Sobin;Jerzy Lasota;Jerzy Lasota

  • Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

    Markku Miettinen;Hala Makhlouf;Leslie H Sobin;Jerzy Lasota

  • Mutations in Exon 11 of c-Kit Occur Preferentially in Malignant versus Benign Gastrointestinal Stromal Tumors and Do Not Occur in Leiomyomas or Leiomyosarcomas

    Jerzy Lasota;Marek Jasinski;Maarit Sarlomo-Rikala;Markku Miettinen

  • Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review

    Markku Miettinen;Mourad Majidi;Jerzy Lasota

  • KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation.

    Markku Miettinen;Jerzy Lasota

  • Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas.

    Markku Miettinen;Maarit Sarlomo-Rikala;Leslie H. Sobin;Jerzy Lasota

  • Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases.

    Markku Miettinen;John F Fetsch;Leslie H Sobin;Jerzy Lasota

  • DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.

    Markku Miettinen;Zeng-Feng Wang;Jerzy Lasota

  • Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours

    J Lasota;M Miettinen

  • Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases.

    Markku Miettinen;Maarit Sarlomo-Rikala;Leslie H. Sobin;Jerzy Lasota

  • Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases.

    Jerzy Lasota;Agnieszka Wozniak;Agnieszka Wozniak;Maarit Sarlomo-Rikala;Janusz Rys

  • Gastrointestinal Stromal Tumors (GISTs): Definition, Occurrence, Pathology, Differential Diagnosis and Molecular Genetics*

    Markku Miettinen;Jerzy Lasota

  • SUCCINATE DEHYDROGENASE DEFICIENT GISTS – A CLINICOPATHOLOGIC, IMMUNOHISTOCHEMICAL, AND MOLECULAR GENETIC STUDY OF 66 GASTRIC GISTS WITH PREDILECTION TO YOUNG AGE

    Markku Miettinen;Zeng-Feng Wang;Maarit Sarlomo-Rikala;Czeslaw Osuch

  • Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature.

    Markku Miettinen;Jerzy Lasota;Leslie H Sobin

Frequent Co-Authors

Markku Miettinen
Markku Miettinen National Cancer Institute
Leslie H. Sobin
Leslie H. Sobin National Cancer Institute
Klaus Weber
Klaus Weber Max Planck Society
Mary Osborn
Mary Osborn Max Planck Institute for Biophysical Chemistry
Christopher L. Corless
Christopher L. Corless Oregon Health & Science University
Lee J. Helman
Lee J. Helman Children's Hospital of Los Angeles
Leif C. Andersson
Leif C. Andersson University of Helsinki
Sakari Knuutila
Sakari Knuutila University of Helsinki
Paul S. Meltzer
Paul S. Meltzer National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

There are many alternative paths in healthcare that don’t require pre-medical degrees or traditional medical school routes. For those with a bachelor’s in a non-nursing field who want to transition quickly into advanced nursing roles, direct entry msn programs for non-nursing majors online offer intensive coursework and flexible online options.

If you prefer a faster track into nursing, several online adn programs for non nurses provide pathways to become a registered nurse without extensive prerequisites.

Healthcare careers are also accessible through administrative roles. For example, there are a variety of medical billing and coding schools that accept fafsa, which can ease financial burdens and open doors to well-paying positions in medical administration.

Some nursing programs now remove barriers for applicants by not requiring standardized entrance tests. Explore options like an lpn program no entrance exam for a streamlined admissions process.

These online degrees and alternative career pathways provide multiple entry points into the growing healthcare sector, catering to diverse backgrounds and career goals.

Best Scientists Citing Jerzy Lasota

Trending Scientists

Recently Published Articles